Risk for COVID-19 Infection Increased With Common Cancers
Patients with 13 common cancer types have a significantly increased risk for COVID-19 infection and significantly worse outcomes.
Cancer
Hepatocellular Carcinoma May Present at Earlier Stage of Liver Disease in Black Patients With HCV
Investigators evaluated the incidence of HCC in the absence of cirrhosis in Black patients with HCV.
Antifungal Prophylaxis in Hematological Disease or Hematopoietic Stem Cell Transplantation
Investigators summarized the evidence on the efficacy and adverse effects of antifungal agents in patients with hematological disease or undergoing hematopoietic stem cell transplantation.
Higher Mortality Among COVID-19 Patients with Cancer
Investigators compared the clinical course, risk factors, and outcomes of cancer patients with COVID-19 with non-cancer patients with COVID-19.
Lower Measles and Mumps Seroprotection in Cancer Patients
Study authors measured seroprevalence of measles and mumps among cancer patients and compared seroprevalence based on demographic, disease, and treatment subgroups.
Antibiotic Use With Immune Checkpoint Inhibitors Associated With Poor Outcomes in Cancer Patients
Study authors sought to determine the effect of antibiotic use and immune checkpoint inhibitors on overall survival, profession-free survival, response rate, and progressive disease rate in cancer patients.
New Gastric Cancer Prevention Guidelines for Eradicating H pylori
A global consensus meeting was convened to go over current evidence and knowledge gaps and propose collaborative studies on population-wide screening and eradication of Helicobacter pylori for the prevention of gastric cancer (GC).
COVID-19–Free Surgical Pathways Benefit Patients Undergoing Elective Cancer Surgery
Elective cancer surgery within COVID-19–free surgical pathways results in lower pulmonary complication, SARS-CoV-2 infection, and mortality rates.
How the Coronavirus Pandemic May Affect Cancer Clinical Trials
Risks of moving clinical trials online include missing key information about the patient experience — and higher dropout rates could also impair the overall quality of trials.
COVID-19-Related Delays in CRC Screening Expected to Cause Increased Mortality
The potential consequences of delaying CRC screening due to the COVID-19 pandemic may lead to an increase in CRC mortality.
-
Loading...
-
Loading...
Next post in COVID19
